Alenson Carman 4
4 · Prime Medicine, Inc. · Filed Apr 4, 2023
Insider Transaction Report
Form 4
Alenson Carman
See Remarks
Transactions
- Award
Stock Option (right to buy)
2023-03-31+90,498→ 90,498 totalExercise: $12.30Exp: 2033-03-31→ Common Stock (90,498 underlying)
Footnotes (1)
- [F1]1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 31, 2023, subject to the Reporting Person's continued service on each such vesting date.